Over the past six months, IOI Properties shares have surged by around 50% to close at RM1.77 ($0.51) on Oct 18. In contrast, many listed developers here have traded sideways at best. Rather than press on this distinction, CEO Lee Yeow Seng diplomatically points out that different property companies are going through different phases. Some might be taking a hit from the valuation of their London assets; others may be hurt because of exposure in China and Hong Kong.
Despite the recent gain, IOI Properties’ share price is still at 0.44x of its NAV per share of RM4.05 as at June 30. Lee prefers to focus on how he can create value for shareholders rather than lamenting about this gap.
With the completion of IOI Central Boulevard Towers, IOI Properties will stand to collect an annual income of around $200 million, estimates Lee. This will add significantly to the company’s revenue from investment properties, which stood at RM491 million in FY2023, up from RM364 million in FY2022. As a proportion of total revenue, that’s an increase from around 14% to nearly a fifth. With this additional cash flow, the company will be able to reduce its gearing, which stands at 67.5% as at June 30.
More interestingly, the company will have a good platform to recycle its capital via a Singapore-listed office REIT, which will also include IOI Properties’ share of South Beach Tower. City Developments, if it wants to put its share in the REIT, will be a bonus, but IOI Properties can go ahead alone, says Lee. “It is about time we unlock value for our shareholders,” he adds.
Lee believes that a REIT listed in Singapore makes sense because this is an asset class readily understood by investors here. Upon completion of IOI Central Boulevard Towers, IOI’s logo will claim its spot in the Singapore CBD skyline. This improved visibility — both figuratively and literally — will presumably lead to better recognition among investors too.
He disagrees with suggestions that IOI Central Boulevard Towers is too new to be included in a REIT. Some REIT managers figure they need to let a particular asset “stabilise” first — with at least one leasing cycle of three years — before selling the asset into a REIT. Not so from Lee’s perspective. “If I can lock in at $15, I am happy to leave something behind on the table for other investors,” says Lee, referring to the rental rates and upside he is projecting from leasing out IOI Central Boulevard Towers.
Besides the office REIT, Lee is potentially securitising some of the mall and hospitality assets in Malaysia too. As for IOI Properties itself, Lee will keep its primary listing in Malaysia.
Based on Bloomberg data, IOI Properties is viewed positively by all seven analysts covering the stock. “FY2024 represents an important execution year for IOI Properties given the execution for two of its largest projects, namely the commencement of IOI Central Boulevard Towers and the launch of Marina View Residences,” writes Hong Leong Investment Bank analyst Tan Kai Shuen, the most bullish with his RM2.48 price target, raised from RM2.10 previously.
In his Oct 5 report, Tan notes that IOI Properties is on track to achieve new records among Malaysian developers from the more than RM10 billion in gross development value (GDV) of new projects to be launched. With an impending RM20 billion portfolio of investment properties following the addition of IOI Central Boulevard Towers, IOI Properties would be overtaking KLCC REIT which owns RM15.7 billion worth as at June 30.

hi guys,

just checked online the selling price of Uniglove's antimicrobial glove, the selling price is crazy. It is close to USD 250 per 1000 pcs. Please refer to the link below.

https://www.safetygloves.co.uk/unigloves-fortified-gf001-antimicrobial-blue-nitrile-gloves.html

Even though this selling price is from the dealer or distributor. But let's assume Uniglove is selling at USD 150 to the distributor. What kind of profit they are making??

Besides Hartalega, UG Healthcare which listed in SGX can also produce Antimicrobial gloves. Please refer to the link below.

https://unigloves.co.uk/biocote-antimicrobial-gloves-fortified-range-unigloves

There is another glove maker which listed in SGX is missed from your comparison list.

You may look into UG Healthcare.

Actually UG Healthcare's Uniglove already got the approval from FDA on their Antimicrobial gloves.

This share is definitely a hidden gem which listed in SGX.

Finally there is a research paper for UG..

https://rfs.cgs-cimb.com/api/download?file=17C33388-4C23-4941-89F4-41F...

Hidden gem...

https://rfs.cgs-cimb.com/api/download?file=17C33388-4C23-4941-89F4-41F...

Hidden gem...

https://rfs.cgs-cimb.com/api/download?file=17C33388-4C23-4941-89F4-41F...

Hidden gem.

https://rfs.cgs-cimb.com/api/download?file=17C33388-4C23-4941-89F4-41FEDF4D0B84

Hidden gem...

https://rfs.cgs-cimb.com/api/download?file=17C33388-4C23-4941-89F4-41FEDF4D0B84

@pelhamblackfund, agreed with you that UG's scale is smaller but it is OBM. OBM has hgiher profit margin and it's North and South America revenue is increasing these few quarters.

Can refer to the link below.

https://unigloves.co.uk/fortified-biocote-antimicrobial-gloves

There is another Malaysia glove company which listed in SGX producing Antimicrobial glove. It's business module is same as Supermax (OBM) and it had launched Antimicrobial glove earlier than Hartalega. It is UG Healthcare (41A).
It has own distribution centers in German, UK, US, Nigeria and Brazil. It is worth to have a look on it.

Another Malaysia glove manufacturer which is OBM which listed in SGX is also producing such glove. This company has distribution centers at German, UK, US, Brazil and Nigeria. All of these countries are badly affected by Covid-19.

Please refer to the link below.

https://www.biocote.com/partners/unigloves/

erkongseng. You can have a look at UG healthcare, Malaysia glove company which listed in SGX

If you guys do a deep research on UG Healthcare (Malaysia’s company listed in Singapore), you guys will realize that it is quite similar to Malaysia listed Supermax and Top Glove. The reason Supermax and Top Glove up alot since Supermax release their quarter report is because these 2 companies are distributing their own brand of glove which lead to higher profit margin. You guys can understand further from the video as per below link. After watching, you guys can go read UG's report and you guys will realize that UG has their own distribution center at China, Nigeria, UK, German, US and Brazil. Despite UG didnt own 100% of share of these companies, but definitely it helps UG to have better profit. Also, these coutries are badly affected by Covid-19.

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-28-story-h15......

Also, not to neglect that Ug Healthcare German is also selling mask, PPE, disinfection, protective clothes etc. All these products are high demand product during this Covid-19. Please refer to the link to understand better.

Besides, UG Healthcare Nigeria is also very interesting distribution center as it is selling the similar products that UG Healthcare German is selling but on top of that, it is also selling infra-red thermometer which is also high demand. Please refer to the link below.

https://www.unimedicalhealthcare.com/aboutus.html...

The link below will enable you to understand better about Uniglove UK. Even though it is old news but it definitely will be benefited during this pandemic as it is Europe’s first antimicrobial nitrile glove.

https://www.hsmsearch.com/page_960209.asp...

https://www.buildingbetterhealthcare.com/news/article_page/Two_firms_j...

https://unigloves.co.uk/fortified-biocote-antimicrobial-gloves...

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-29-story-h15...

If we do comparison between Rubberex Malaysia and UG Healthcare. UG healthcare is lagging behind.
Rubberex market cap = (rm3.56/3.06) * 252195617 = SGD 293,404,051
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

UG yearly capacity is around 3B where Rubberex only 2B.

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(293404051 (Rubberex’s market cap) * 3B (UG’s capacity)) / 2b (Rubberex’s market cap) = 214685891

UG’s potential share price = 214685891 / 196092856 (no of UG’s issued share)= SGD 1.09

If we do comparison between Careplus Malaysia and UG Healthcare. UG healthcare is also lagging behind.
Careplus market cap = (rm1.40/3.06) * 531,359,799 = SGD 243,105,790
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(243105790 (careplus’ market cap) * 3B (UG’s capacity)) / 4.1B (careplus’ capacity) = 177882285.4

UG’s potential share price = 177882285.4 / 196092856 (no of UG’s issued share) = SGD 0.907

Even though careplus produce 1B pcs extra compared to UG healthcare, but UG healthcare will benefitted from it’s own brand of glove as well as it’s distribution centers in UK, Brazil and Nigeria are selling others PPE and tools which are badly needed during this pandemic.

If we use the method of one of the Malaysia’s famous investor to calculation the price per glove, UG healthcare is on 0.09 per glove which is much more cheaper compared to peers.




Even though the last quarter report seems like “poor”, but it was mainly affected by the production modification cost where the board has decided to on hold the modification in order to cope with the sudden spike of demand. Do take note that the modification at the end will benefit the group as well. UG has reported positive earning for the last 3 FY. In fact, increase of marketing expenses is good for the company in long run as once everyone know about “Uniglove”, the marketing expenses eventually will come back and profit will go up.

Most likely August report will have flying colour result.

Stay tuned!!!

If you guys do a deep research on UG Healthcare (Malaysia’s company listed in Singapore), you guys will realize that it is quite similar to Malaysia listed Supermax and Top Glove. The reason Supermax and Top Glove up alot since Supermax release their quarter report is because these 2 companies are distributing their own brand of glove which lead to higher profit margin. You guys can understand further from the video as per below link. After watching, you guys can go read UG's report and you guys will realize that UG has their own distribution center at China, Nigeria, UK, German, US and Brazil. Despite UG didnt own 100% of share of these companies, but definitely it helps UG to have better profit. Also, these coutries are badly affected by Covid-19.

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-28-story-h15......

Also, not to neglect that Ug Healthcare German is also selling mask, PPE, disinfection, protective clothes etc. All these products are high demand product during this Covid-19. Please refer to the link to understand better.

Besides, UG Healthcare Nigeria is also very interesting distribution center as it is selling the similar products that UG Healthcare German is selling but on top of that, it is also selling infra-red thermometer which is also high demand. Please refer to the link below.

https://www.unimedicalhealthcare.com/aboutus.html...

The link below will enable you to understand better about Uniglove UK. Even though it is old news but it definitely will be benefited during this pandemic as it is Europe’s first antimicrobial nitrile glove.

https://www.hsmsearch.com/page_960209.asp...

https://www.buildingbetterhealthcare.com/news/article_page/Two_firms_j...

https://unigloves.co.uk/fortified-biocote-antimicrobial-gloves...

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-29-story-h15...

If we do comparison between Rubberex Malaysia and UG Healthcare. UG healthcare is lagging behind.
Rubberex market cap = (rm3.56/3.06) * 252195617 = SGD 293,404,051
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

UG yearly capacity is around 3B where Rubberex only 2B.

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(293404051 (Rubberex’s market cap) * 3B (UG’s capacity)) / 2b (Rubberex’s market cap) = 214685891

UG’s potential share price = 214685891 / 196092856 (no of UG’s issued share)= SGD 1.09

If we do comparison between Careplus Malaysia and UG Healthcare. UG healthcare is also lagging behind.
Careplus market cap = (rm1.40/3.06) * 531,359,799 = SGD 243,105,790
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(243105790 (careplus’ market cap) * 3B (UG’s capacity)) / 4.1B (careplus’ capacity) = 177882285.4

UG’s potential share price = 177882285.4 / 196092856 (no of UG’s issued share) = SGD 0.907

Even though careplus produce 1B pcs extra compared to UG healthcare, but UG healthcare will benefitted from it’s own brand of glove as well as it’s distribution centers in UK, Brazil and Nigeria are selling others PPE and tools which are badly needed during this pandemic.

If we use the method of one of the Malaysia’s famous investor to calculation the price per glove, UG healthcare is on 0.09 per glove which is much more cheaper compared to peers.




Even though the last quarter report seems like “poor”, but it was mainly affected by the production modification cost where the board has decided to on hold the modification in order to cope with the sudden spike of demand. Do take note that the modification at the end will benefit the group as well. UG has reported positive earning for the last 3 FY. In fact, increase of marketing expenses is good for the company in long run as once everyone know about “Uniglove”, the marketing expenses eventually will come back and profit will go up.

Most likely August report will have flying colour result.

Stay tuned!!!

If you guys do a deep research on UG Healthcare (Malaysia’s company listed in Singapore), you guys will realize that it is quite similar to Malaysia listed Supermax and Top Glove. The reason Supermax and Top Glove up alot since Supermax release their quarter report is because these 2 companies are distributing their own brand of glove which lead to higher profit margin. You guys can understand further from the video as per below link. After watching, you guys can go read UG's report and you guys will realize that UG has their own distribution center at China, Nigeria, UK, German, US and Brazil. Despite UG didnt own 100% of share of these companies, but definitely it helps UG to have better profit. Also, these coutries are badly affected by Covid-19.

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-28-story-h15......

Also, not to neglect that Ug Healthcare German is also selling mask, PPE, disinfection, protective clothes etc. All these products are high demand product during this Covid-19. Please refer to the link to understand better.

Besides, UG Healthcare Nigeria is also very interesting distribution center as it is selling the similar products that UG Healthcare German is selling but on top of that, it is also selling infra-red thermometer which is also high demand. Please refer to the link below.

https://www.unimedicalhealthcare.com/aboutus.html...

The link below will enable you to understand better about Uniglove UK. Even though it is old news but it definitely will be benefited during this pandemic as it is Europe’s first antimicrobial nitrile glove.

https://www.hsmsearch.com/page_960209.asp...

https://www.buildingbetterhealthcare.com/news/article_page/Two_firms_j...

https://unigloves.co.uk/fortified-biocote-antimicrobial-gloves...

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-29-story-h15...

If we do comparison between Rubberex Malaysia and UG Healthcare. UG healthcare is lagging behind.
Rubberex market cap = (rm3.56/3.06) * 252195617 = SGD 293,404,051
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

UG yearly capacity is around 3B where Rubberex only 2B.

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(293404051 (Rubberex’s market cap) * 3B (UG’s capacity)) / 2b (Rubberex’s market cap) = 214685891

UG’s potential share price = 214685891 / 196092856 (no of UG’s issued share)= SGD 1.09

If we do comparison between Careplus Malaysia and UG Healthcare. UG healthcare is also lagging behind.
Careplus market cap = (rm1.40/3.06) * 531,359,799 = SGD 243,105,790
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(243105790 (careplus’ market cap) * 3B (UG’s capacity)) / 4.1B (careplus’ capacity) = 177882285.4

UG’s potential share price = 177882285.4 / 196092856 (no of UG’s issued share) = SGD 0.907

Even though careplus produce 1B pcs extra compared to UG healthcare, but UG healthcare will benefitted from it’s own brand of glove as well as it’s distribution centers in UK, Brazil and Nigeria are selling others PPE and tools which are badly needed during this pandemic.

If we use the method of one of the Malaysia’s famous investor to calculation the price per glove, UG healthcare is on 0.09 per glove which is much more cheaper compared to peers.




Even though the last quarter report seems like “poor”, but it was mainly affected by the production modification cost where the board has decided to on hold the modification in order to cope with the sudden spike of demand. Do take note that the modification at the end will benefit the group as well. UG has reported positive earning for the last 3 FY. In fact, increase of marketing expenses is good for the company in long run as once everyone know about “Uniglove”, the marketing expenses eventually will come back and profit will go up.

Most likely August report will have flying colour result.

Stay tuned!!!

If you guys do a deep research on UG Healthcare (Malaysia’s company listed in Singapore), you guys will realize that it is quite similar to Malaysia listed Supermax and Top Glove. The reason Supermax and Top Glove up alot since Supermax release their quarter report is because these 2 companies are distributing their own brand of glove which lead to higher profit margin. You guys can understand further from the video as per below link. After watching, you guys can go read UG's report and you guys will realize that UG has their own distribution center at China, Nigeria, UK, German, US and Brazil. Despite UG didnt own 100% of share of these companies, but definitely it helps UG to have better profit. Also, these coutries are badly affected by Covid-19.

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-28-story-h15......

Also, not to neglect that Ug Healthcare German is also selling mask, PPE, disinfection, protective clothes etc. All these products are high demand product during this Covid-19. Please refer to the link to understand better.

Besides, UG Healthcare Nigeria is also very interesting distribution center as it is selling the similar products that UG Healthcare German is selling but on top of that, it is also selling infra-red thermometer which is also high demand. Please refer to the link below.

https://www.unimedicalhealthcare.com/aboutus.html...

The link below will enable you to understand better about Uniglove UK. Even though it is old news but it definitely will be benefited during this pandemic as it is Europe’s first antimicrobial nitrile glove.

https://www.hsmsearch.com/page_960209.asp...

https://www.buildingbetterhealthcare.com/news/article_page/Two_firms_j...

https://unigloves.co.uk/fortified-biocote-antimicrobial-gloves...

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-29-story-h15...

If we do comparison between Rubberex Malaysia and UG Healthcare. UG healthcare is lagging behind.
Rubberex market cap = (rm3.56/3.06) * 252195617 = SGD 293,404,051
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

UG yearly capacity is around 3B where Rubberex only 2B.

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(293404051 (Rubberex’s market cap) * 3B (UG’s capacity)) / 2b (Rubberex’s market cap) = 214685891

UG’s potential share price = 214685891 / 196092856 (no of UG’s issued share)= SGD 1.09

If we do comparison between Careplus Malaysia and UG Healthcare. UG healthcare is also lagging behind.
Careplus market cap = (rm1.40/3.06) * 531,359,799 = SGD 243,105,790
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(243105790 (careplus’ market cap) * 3B (UG’s capacity)) / 4.1B (careplus’ capacity) = 177882285.4

UG’s potential share price = 177882285.4 / 196092856 (no of UG’s issued share) = SGD 0.907

Even though careplus produce 1B pcs extra compared to UG healthcare, but UG healthcare will benefitted from it’s own brand of glove as well as it’s distribution centers in UK, Brazil and Nigeria are selling others PPE and tools which are badly needed during this pandemic.

If we use the method of one of the Malaysia’s famous investor to calculation the price per glove, UG healthcare is on 0.09 per glove which is much more cheaper compared to peers.




Even though the last quarter report seems like “poor”, but it was mainly affected by the production modification cost where the board has decided to on hold the modification in order to cope with the sudden spike of demand. Do take note that the modification at the end will benefit the group as well. UG has reported positive earning for the last 3 FY. In fact, increase of marketing expenses is good for the company in long run as once everyone know about “Uniglove”, the marketing expenses eventually will come back and profit will go up.

Most likely August report will have flying colour result.

Stay tuned!!!

If you guys do a deep research on UG Healthcare (Malaysia’s company listed in Singapore), you guys will realize that it is quite similar to Malaysia listed Supermax and Top Glove. The reason Supermax and Top Glove up alot since Supermax release their quarter report is because these 2 companies are distributing their own brand of glove which lead to higher profit margin. You guys can understand further from the video as per below link. After watching, you guys can go read UG's report and you guys will realize that UG has their own distribution center at China, Nigeria, UK, German, US and Brazil. Despite UG didnt own 100% of share of these companies, but definitely it helps UG to have better profit. Also, these coutries are badly affected by Covid-19.

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-28-story-h15......

Also, not to neglect that Ug Healthcare German is also selling mask, PPE, disinfection, protective clothes etc. All these products are high demand product during this Covid-19. Please refer to the link to understand better.

Besides, UG Healthcare Nigeria is also very interesting distribution center as it is selling the similar products that UG Healthcare German is selling but on top of that, it is also selling infra-red thermometer which is also high demand. Please refer to the link below.

https://www.unimedicalhealthcare.com/aboutus.html...

The link below will enable you to understand better about Uniglove UK. Even though it is old news but it definitely will be benefited during this pandemic as it is Europe’s first antimicrobial nitrile glove.

https://www.hsmsearch.com/page_960209.asp...

https://www.buildingbetterhealthcare.com/news/article_page/Two_firms_j...

https://unigloves.co.uk/fortified-biocote-antimicrobial-gloves...

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-29-story-h15...

If we do comparison between Rubberex Malaysia and UG Healthcare. UG healthcare is lagging behind.
Rubberex market cap = (rm3.56/3.06) * 252195617 = SGD 293,404,051
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

UG yearly capacity is around 3B where Rubberex only 2B.

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(293404051 (Rubberex’s market cap) * 3B (UG’s capacity)) / 2b (Rubberex’s market cap) = 214685891

UG’s potential share price = 214685891 / 196092856 (no of UG’s issued share)= SGD 1.09

If we do comparison between Careplus Malaysia and UG Healthcare. UG healthcare is also lagging behind.
Careplus market cap = (rm1.40/3.06) * 531,359,799 = SGD 243,105,790
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(243105790 (careplus’ market cap) * 3B (UG’s capacity)) / 4.1B (careplus’ capacity) = 177882285.4

UG’s potential share price = 177882285.4 / 196092856 (no of UG’s issued share) = SGD 0.907

Even though careplus produce 1B pcs extra compared to UG healthcare, but UG healthcare will benefitted from it’s own brand of glove as well as it’s distribution centers in UK, Brazil and Nigeria are selling others PPE and tools which are badly needed during this pandemic.

If we use the method of one of the Malaysia’s famous investor to calculation the price per glove, UG healthcare is on 0.09 per glove which is much more cheaper compared to peers.




Even though the last quarter report seems like “poor”, but it was mainly affected by the production modification cost where the board has decided to on hold the modification in order to cope with the sudden spike of demand. Do take note that the modification at the end will benefit the group as well. UG has reported positive earning for the last 3 FY. In fact, increase of marketing expenses is good for the company in long run as once everyone know about “Uniglove”, the marketing expenses eventually will come back and profit will go up.

Most likely August report will have flying colour result.

Stay tuned!!!

If you guys do a deep research on UG Healthcare (Malaysia’s company listed in Singapore), you guys will realize that it is quite similar to Malaysia listed Supermax and Top Glove. The reason Supermax and Top Glove up alot since Supermax release their quarter report is because these 2 companies are distributing their own brand of glove which lead to higher profit margin. You guys can understand further from the video as per below link. After watching, you guys can go read UG's report and you guys will realize that UG has their own distribution center at China, Nigeria, UK, German, US and Brazil. Despite UG didnt own 100% of share of these companies, but definitely it helps UG to have better profit. Also, these coutries are badly affected by Covid-19.

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-28-story-h15......

Also, not to neglect that Ug Healthcare German is also selling mask, PPE, disinfection, protective clothes etc. All these products are high demand product during this Covid-19. Please refer to the link to understand better.

Besides, UG Healthcare Nigeria is also very interesting distribution center as it is selling the similar products that UG Healthcare German is selling but on top of that, it is also selling infra-red thermometer which is also high demand. Please refer to the link below.

https://www.unimedicalhealthcare.com/aboutus.html...

The link below will enable you to understand better about Uniglove UK. Even though it is old news but it definitely will be benefited during this pandemic as it is Europe’s first antimicrobial nitrile glove.

https://www.hsmsearch.com/page_960209.asp...

https://www.buildingbetterhealthcare.com/news/article_page/Two_firms_j...

https://unigloves.co.uk/fortified-biocote-antimicrobial-gloves...

https://klse.i3investor.com/blogs/kianweiaritcles/2020-05-29-story-h15...

If we do comparison between Rubberex Malaysia and UG Healthcare. UG healthcare is lagging behind.
Rubberex market cap = (rm3.56/3.06) * 252195617 = SGD 293,404,051
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

UG yearly capacity is around 3B where Rubberex only 2B.

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(293404051 (Rubberex’s market cap) * 3B (UG’s capacity)) / 2b (Rubberex’s market cap) = 214685891

UG’s potential share price = 214685891 / 196092856 (no of UG’s issued share)= SGD 1.09

If we do comparison between Careplus Malaysia and UG Healthcare. UG healthcare is also lagging behind.
Careplus market cap = (rm1.40/3.06) * 531,359,799 = SGD 243,105,790
UG heathcare market cap =（SGD 0.47 * 196092856）= SGD 92,163,642

So if we use production capacity ratio to market cap as below calculation. UG should worth SGD
(243105790 (careplus’ market cap) * 3B (UG’s capacity)) / 4.1B (careplus’ capacity) = 177882285.4

UG’s potential share price = 177882285.4 / 196092856 (no of UG’s issued share) = SGD 0.907

Even though careplus produce 1B pcs extra compared to UG healthcare, but UG healthcare will benefitted from it’s own brand of glove as well as it’s distribution centers in UK, Brazil and Nigeria are selling others PPE and tools which are badly needed during this pandemic.

If we use the method of one of the Malaysia’s famous investor to calculation the price per glove, UG healthcare is on 0.09 per glove which is much more cheaper compared to peers.




Even though the last quarter report seems like “poor”, but it was mainly affected by the production modification cost where the board has decided to on hold the modification in order to cope with the sudden spike of demand. Do take note that the modification at the end will benefit the group as well. UG has reported positive earning for the last 3 FY. In fact, increase of marketing expenses is good for the company in long run as once everyone know about “Uniglove”, the marketing expenses eventually will come back and profit will go up.

Most likely August report will have flying colour result.

Stay tuned!!!